My Bibliography

select

Yun NK, Rouhani SJ, Bestvina CM, Ritz EM, Gilmore BA, Tarhoni I, Borgia JA, Batus M, Bonomi PD, Fidler MJ. Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers (Basel). 2021 Mar 20;13(6). doi: 10.3390/cancers13061426. PubMed PMID: 33804721; PubMed Central PMCID: PMC8003851.

select

Tarhoni I, Wakefield CJ, Kollipara R, Fidler MJ, Batus M, Bonomi P, Borgia JA. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 Mar;490:112956. doi: 10.1016/j.jim.2021.112956. Epub 2021 Jan 9. PubMed PMID: 33434603; NIHMSID:NIHMS1723736.

select

Bonomi P, Batus M, Fidler MJ, Borgia JA. Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patients. Ann Transl Med. 2017 Mar;5(6):152. doi: 10.21037/atm.2017.03.20. PubMed PMID: 28462232; PubMed Central PMCID: PMC5395479.

select

Derman BA, Macklis JN, Azeem MS, Sayidine S, Basu S, Batus M, Esmail F, Borgia JA, Bonomi P, Fidler MJ. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. BMC Cancer. 2017 Feb 16;17(1):141. doi: 10.1186/s12885-017-3122-y. PubMed PMID: 28209123; PubMed Central PMCID: PMC5312530.

select

Sher DJ, Rusthoven CG, Khan SA, Fidler MJ, Zhu H, Koshy M. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma. Cancer. 2017 Jan 1;123(2):273-282. doi: 10.1002/cncr.30255. Epub 2016 Sep 20. PubMed PMID: 27649421.

select

O'Mahony S, Nathan S, Mohajer R, Bonomi P, Batus M, Fidler MJ, Wells K, Kern N, Sims S, Amin D. Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale. Am J Hosp Palliat Care. 2016 May;33(4):374-80. doi: 10.1177/1049909115570707. Epub 2015 Feb 10. PubMed PMID: 25670717.

select

Herbst RS, Baas P, Kim DW, Felip E, Pérez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, de Castro G Jr, Garrido M, Lubiniecki GM, Shentu Y, Im E, Dolled-Filhart M, Garon EB. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016 Apr 9;387(10027):1540-1550. doi: 10.1016/S0140-6736(15)01281-7. Epub 2015 Dec 19. PubMed PMID: 26712084.

select

Sher DJ, Fidler MJ, Tishler RB, Stenson K, al-Khudari S. Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):512-22. doi: 10.1016/j.ijrobp.2015.11.006. Epub 2015 Nov 10. PubMed PMID: 26867880.

select

Sher DJ, Schwartz DL, Nedzi L, Khan S, Hughes R, Fidler MJ, Koshy M. Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis. Oral Oncol. 2016 Mar;54:58-67. doi: 10.1016/j.oraloncology.2015.12.008. Epub 2016 Jan 18. PubMed PMID: 26794877.

select

Dandekar VK, Young J, Kiel K, Bonomi P, Fidler MJ, Batus M, Sher DJ. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer. Am J Clin Oncol. 2015 Dec;38(6):605-9. doi: 10.1097/COC.0000000000000007. PubMed PMID: 24781341.

select

Derman BA, Mileham KF, Bonomi PD, Batus M, Fidler MJ. Treatment of advanced squamous cell carcinoma of the lung: a review. Transl Lung Cancer Res. 2015 Oct;4(5):524-32. doi: 10.3978/j.issn.2218-6751.2015.06.07. Review. PubMed PMID: 26629421; PubMed Central PMCID: PMC4630512.

select

Ziel E, Hermann G, Sen N, Bonomi P, Liptay MJ, Fidler MJ, Batus M, Warren WH, Chmielewski G, Sher DJ. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response. J Thorac Oncol. 2015 Oct;10(10):1475-80. doi: 10.1097/JTO.0000000000000639. PubMed PMID: 26398822.

select

Fidler MJ. Practice-Changing Findings. Oncology (Williston Park). 2015 Jul;29(7):502-4. PubMed PMID: 26178345.

select

Sher DJ, Fidler MJ, Seder CW, Liptay MJ, Koshy M. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):307-16. doi: 10.1016/j.ijrobp.2015.01.032. Epub 2015 Mar 30. PubMed PMID: 25838187.

select

Sher DJ, Fidler MJ, Liptay MJ, Koshy M. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer. Lung Cancer. 2015 Jun;88(3):267-74. doi: 10.1016/j.lungcan.2015.03.015. Epub 2015 Mar 21. PubMed PMID: 25862147.

select

Edelman MJ, Tan MT, Fidler MJ, Sanborn RE, Otterson G, Sequist LV, Evans TL, Schneider BJ, Keresztes R, Rogers JS, de Mayolo JA, Feliciano J, Yang Y, Medeiros M, Zaknoen SL. Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer. J Clin Oncol. 2015 Jan 10;33(2):189-94. doi: 10.1200/JCO.2014.55.5789. Epub 2014 Dec 1. PubMed PMID: 25452446; PubMed Central PMCID: PMC4890680.

select

Garg S, Gielda BT, Kiel K, Turian JV, Fidler MJ, Batus M, Bonomi P, Sher DJ. Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy. Pract Radiat Oncol. 2014 Sep-Oct;4(5):342-348. doi: 10.1016/j.prro.2013.12.002. Epub 2014 Jan 16. PubMed PMID: 25194104.

select

Somaiah N, Fidler MJ, Garrett-Mayer E, Wahlquist A, Shirai K, Buckingham L, Hensing T, Bonomi P, Simon GR. Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung. Oncoscience. 2014;1(8):522-528. doi: 10.18632/oncoscience.72. eCollection 2014. PubMed PMID: 25594059; PubMed Central PMCID: PMC4278331.

select

Sher DJ, Koshy M, Liptay MJ, Fidler MJ. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Cancer. 2014 Jul 1;120(13):2060-8. doi: 10.1002/cncr.28677. Epub 2014 Apr 1. PubMed PMID: 24692108.

select

Sher DJ, Liptay MJ, Fidler MJ. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):303-12. doi: 10.1016/j.ijrobp.2014.01.033. Epub 2014 Mar 28. PubMed PMID: 24685443.

select

Dandekar V, Morgan T, Turian J, Fidler MJ, Showel J, Nielsen T, Coleman J, Diaz A, Sher DJ. Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing. Oral Oncol. 2014 May;50(5):520-6. doi: 10.1016/j.oraloncology.2014.02.009. Epub 2014 Mar 6. PubMed PMID: 24613544.

select

Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2013 Jul;14(4):370-5. doi: 10.1016/j.cllc.2012.10.009. Epub 2012 Dec 20. PubMed PMID: 23260389.

select

Fidler MJ, Basu S, Buckingham L, Walters K, McCormack S, Batus M, Coon J 4th, Bonomi P. Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer. Anticancer Res. 2012 May;32(5):1705-10. PubMed PMID: 22593449.

select

Herskovic A, Russell W, Liptay M, Fidler MJ, Al-Sarraf M. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol. 2012 May;23(5):1095-1103. doi: 10.1093/annonc/mdr433. Epub 2011 Oct 14. Review. PubMed PMID: 22003242.

select

Fidler MJ, Shersher DD, Borgia JA, Bonomi P. Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls. Ther Adv Med Oncol. 2012 Mar;4(2):51-60. doi: 10.1177/1758834011427576. PubMed PMID: 22423264; PubMed Central PMCID: PMC3296080.

select

Fidler MJ, Morrison LE, Basu S, Buckingham L, Walters K, Batus M, Jacobson KK, Jewell SS, Coon J 4th, Bonomi PD. PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy. Br J Cancer. 2011 Dec 6;105(12):1920-6. doi: 10.1038/bjc.2011.494. Epub 2011 Nov 17. PubMed PMID: 22095222; PubMed Central PMCID: PMC3251891.

select

Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):985-91. doi: 10.1016/j.ijrobp.2010.06.059. Epub 2010 Oct 6. PubMed PMID: 20932684.

select

Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun;6(6):1079-86. doi: 10.1097/JTO.0b013e3182199a7c. PubMed PMID: 21532501.

select

Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Lung Cancer. 2011 Feb;71(2):186-90. doi: 10.1016/j.lungcan.2010.05.006. Epub 2010 Jun 8. PubMed PMID: 20570389.

select

Plate JM, Fidler MJ. Immunotherapy to overcome lung tumor cell-induced escape from immunosurveillance. Immunotherapy. 2010 Nov;2(6):757-60. doi: 10.2217/imt.10.62. PubMed PMID: 21091107.

select

Batus M, Fidler MJ, Bonomi PD. Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer. Expert Rev Anticancer Ther. 2010 Oct;10(10):1589-99. doi: 10.1586/era.10.104. Review. PubMed PMID: 20942630.

select

Fidler MJ, Kim AW, Zusag T, Bonomi P. Treatment of locally advanced non-small cell lung cancer. Clin Adv Hematol Oncol. 2009 Jul;7(7):455-64, 479-80. Review. PubMed PMID: 19701153.

select

Fidler MJ, Argiris A, Patel JD, Johnson DH, Sandler A, Villaflor VM, Coon J 4th, Buckingham L, Kaiser K, Basu S, Bonomi P. The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib. Clin Cancer Res. 2008 Apr 1;14(7):2088-94. doi: 10.1158/1078-0432.CCR-07-4013. PubMed PMID: 18381949.

select

Error occurred: The following PMID is not available: 27676480

select

Error occurred: The following PMID is not available: 27676575

select

Error occurred: The following PMID is not available: 28514740